mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.006 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.006 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.006 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.007 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.008 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.009 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.009 |